Identification of transthyretin variants by sequential proteomic and genomic analysis

被引:47
作者
Bergen, HR
Zeldenrust, SR
Butz, ML
Snow, DS
Dyck, PJ
Dyck, PJB
Klein, CJ
O'Brien, JF
Thibodeau, SN
Muddiman, DC
机构
[1] Mayo Clin & Mayo Fdn, Dept Pathol & Lab Med, Coll Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Mayo Prote Res Ctr, WM keck FT ICR Mass Spectrometry Lab, Coll Med, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Neurol, Peripheral Neuropathy Res Ctr, Coll Med, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[5] Mayo Clin & Mayo Fdn, Coll Med, Dept Hematol, Rochester, MN 55905 USA
关键词
D O I
10.1373/clinchem.2004.033266
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Transthyretin-associated hereditary amyloidosis (ATTR) is an inherited disease in which variants in the primary structure of transthyretin (TTR; prealbumin) lead to the extracellular polymerization of insoluble protein fibrils, causing organ failure and ultimately death when major organs are involved. We have developed an integrated approach to molecular diagnosis with initial analysis of intact plasma TTR by electrospray ionization mass spectrometry (MS) and referral of positive samples for DNA sequence analysis and real-time PCR to confirm the common Gly6Ser polymorphism. Methods: Samples from 6 patients previously diagnosed with ATTR and from 25 controls with (n = 15) or without (n = 10) polyneuropathy were analyzed in a blinded fashion for the presence of variant TTR. TTR protein was extracted with an immunoaffinity resin from 20 muL of archived plasma samples. The purified TTR was reduced with tris(2-carboxyethyl)phosphine and analyzed by MS. The appearance of two peaks (or a single peak shifted in mass indicative of a homozygous variant), including the wild-type mass of 13 761 Da, was indicative of the presence of a variant, and the individual was referred for DNA sequence analysis. Results: MS analysis of intact reduced TTR correctly identified each of six samples known to contain variant TTR. These results were corroborated by subsequent DNA sequence analysis. Additionally, all Gly6Ser polymorphisms were correctly called based on the +30 mass shift and an equal relative abundance of the +30 polymorphism relative to wild-type TTR. No false-positive results were seen. Conclusions: This referral method eliminates the necessity of sequencing most samples and allows screening for the familial forms of amyloidosis in a broad patient population in a timely fashion. This method correctly identified all previously known variants and also identified a novel variant, Val94Ala. (C) 2004 American Association for Clinical Chemistry.
引用
收藏
页码:1544 / 1552
页数:9
相关论文
共 33 条
[21]   LASER-DESORPTION TIME-OF-FLIGHT MASS-SPECTROMETRIC ANALYSIS OF TRANSFERRIN PRECIPITATED WITH ANTISERUM - A UNIQUE SIMPLE METHOD TO IDENTIFY MOLECULAR-WEIGHT VARIANTS [J].
NAKANISHI, T ;
OKAMOTO, N ;
TANAKA, K ;
SHIMIZU, A .
BIOLOGICAL MASS SPECTROMETRY, 1994, 23 (04) :230-233
[22]  
Nelis E, 1996, EUR J HUM GENET, V4, P329
[23]   Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization Fourier-transform ion-cyclotron-resonance mass spectrometry [J].
Nepomuceno, AI ;
Mason, CJ ;
Muddiman, DC ;
Bergen, HR ;
Zeldenrust, SR .
CLINICAL CHEMISTRY, 2004, 50 (09) :1535-1543
[24]   Rapid screening for amyloid-related variant forms of transthyretin is possible by electrospray ionization mass spectrometry [J].
Ranlov, I ;
Ando, Y ;
Ohlsson, PI ;
Holmgren, G ;
Ranlov, PJ ;
Suhr, OB .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (11) :956-959
[25]   Detection and identification of protein variants and adducts in blood and tissues: an application of soft ionization mass spectrometry to clinical diagnosis [J].
Shimizu, A ;
Nakanishi, T ;
Kishikawa, M ;
Miyazaki, A .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 776 (01) :15-30
[26]   THE PREVALENCE OF ISOLATED ATRIAL AMYLOID [J].
STEINER, I .
JOURNAL OF PATHOLOGY, 1987, 153 (04) :395-398
[27]   LIVER-TRANSPLANTATION IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY - FOLLOW-UP OF THE FIRST 20 SWEDISH PATIENTS [J].
SUHR, OB ;
HOLMGREN, G ;
STEEN, L ;
WIKSTROM, L ;
NORDEN, G ;
FRIMAN, S ;
DURAJ, FF ;
GROTH, CG ;
ERICZON, BG .
TRANSPLANTATION, 1995, 60 (09) :933-938
[28]   Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy [J].
Tachibana, N ;
Tokuda, T ;
Yoshida, K ;
Taketomi, T ;
Nakazato, M ;
Li, YF ;
Masuda, Y ;
Ikeda, S .
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1999, 6 (04) :282-288
[29]   Detection of transthyretin variants using immunoprecipitation and matrix-assisted laser desorption/ionization bioreactive probes:: A clinical application of mass spectrometry [J].
Théberge, R ;
Connors, LH ;
Skinner, M ;
Costello, CE .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2000, 11 (02) :172-175
[30]   Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry [J].
Théberge, R ;
Connors, L ;
Skinner, M ;
Skare, J ;
Costello, CE .
ANALYTICAL CHEMISTRY, 1999, 71 (02) :452-459